Diphenidol

Profil Farmakokinetik

Waktu Paruh (Half-Life) 4 hours

Volume Distribusi -

Klirens (Clearance) -

Absorpsi

Well absorbed from gastrointestinal tract following oral administration.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

516 Data

Aclidinium	The risk or severity of adverse effects can be increased when Diphenidol is combined with Aclidinium.
Mianserin	Mianserin may increase the anticholinergic activities of Diphenidol.
Mirabegron	The risk or severity of urinary retention can be increased when Diphenidol is combined with Mirabegron.
Potassium chloride	The risk or severity of gastrointestinal ulceration can be increased when Diphenidol is combined with Potassium chloride.
Pramlintide	The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Diphenidol.
Secretin porcine	The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Diphenidol.
Tiotropium	The risk or severity of adverse effects can be increased when Diphenidol is combined with Tiotropium.
Topiramate	The risk or severity of hyperthermia and oligohydrosis can be increased when Diphenidol is combined with Topiramate.
Umeclidinium	The risk or severity of adverse effects can be increased when Diphenidol is combined with Umeclidinium.
Glycopyrronium	The risk or severity of adverse effects can be increased when Diphenidol is combined with Glycopyrronium.
Botulinum toxin type A	The risk or severity of adverse effects can be increased when Diphenidol is combined with Botulinum toxin type A.
Glucagon	Diphenidol may increase the gastrointestinal motility reducing activities of Glucagon.
Sulpiride	Diphenidol may increase the anticholinergic activities of Sulpiride.
Botulinum toxin type B	The risk or severity of adverse effects can be increased when Diphenidol is combined with Botulinum toxin type B.
Eluxadoline	The risk or severity of constipation can be increased when Diphenidol is combined with Eluxadoline.
Ramosetron	The risk or severity of constipation can be increased when Diphenidol is combined with Ramosetron.
Naltrexone	The risk or severity of adverse effects can be increased when Diphenidol is combined with Naltrexone.
Bezitramide	The risk or severity of adverse effects can be increased when Diphenidol is combined with Bezitramide.
Tramadol	The risk or severity of adverse effects can be increased when Diphenidol is combined with Tramadol.
Morphine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Morphine.
Codeine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Codeine.
Hydromorphone	The risk or severity of adverse effects can be increased when Diphenidol is combined with Hydromorphone.
Methadone	The risk or severity of adverse effects can be increased when Diphenidol is combined with Methadone.
Meperidine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Meperidine.
Oxycodone	The risk or severity of adverse effects can be increased when Diphenidol is combined with Oxycodone.
Butorphanol	The risk or severity of adverse effects can be increased when Diphenidol is combined with Butorphanol.
Dextropropoxyphene	The risk or severity of adverse effects can be increased when Diphenidol is combined with Dextropropoxyphene.
Pentazocine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Pentazocine.
Sufentanil	The risk or severity of adverse effects can be increased when Diphenidol is combined with Sufentanil.
Alfentanil	The risk or severity of adverse effects can be increased when Diphenidol is combined with Alfentanil.
Fentanyl	The risk or severity of adverse effects can be increased when Diphenidol is combined with Fentanyl.
Nalbuphine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Nalbuphine.
Levorphanol	The risk or severity of adverse effects can be increased when Diphenidol is combined with Levorphanol.
Remifentanil	The risk or severity of adverse effects can be increased when Diphenidol is combined with Remifentanil.
Buprenorphine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Buprenorphine.
Hydrocodone	The risk or severity of adverse effects can be increased when Diphenidol is combined with Hydrocodone.
Diphenoxylate	The risk or severity of adverse effects can be increased when Diphenidol is combined with Diphenoxylate.
Oxymorphone	The risk or severity of adverse effects can be increased when Diphenidol is combined with Oxymorphone.
Dezocine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Dezocine.
Levacetylmethadol	The risk or severity of adverse effects can be increased when Diphenidol is combined with Levacetylmethadol.
Methadyl acetate	The risk or severity of adverse effects can be increased when Diphenidol is combined with Methadyl acetate.
Dihydroetorphine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Dihydroetorphine.
Diamorphine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Diamorphine.
Ethylmorphine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Ethylmorphine.
Etorphine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Etorphine.
Dextromoramide	The risk or severity of adverse effects can be increased when Diphenidol is combined with Dextromoramide.
Desomorphine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Desomorphine.
Carfentanil	The risk or severity of adverse effects can be increased when Diphenidol is combined with Carfentanil.
Dihydrocodeine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Dihydrocodeine.
Alphacetylmethadol	The risk or severity of adverse effects can be increased when Diphenidol is combined with Alphacetylmethadol.
Dihydromorphine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Dihydromorphine.
Tapentadol	The risk or severity of urinary retention and constipation can be increased when Diphenidol is combined with Tapentadol.
Ketobemidone	The risk or severity of adverse effects can be increased when Diphenidol is combined with Ketobemidone.
DPDPE	The risk or severity of adverse effects can be increased when Diphenidol is combined with DPDPE.
Lofentanil	The risk or severity of adverse effects can be increased when Diphenidol is combined with Lofentanil.
Opium	The risk or severity of adverse effects can be increased when Diphenidol is combined with Opium.
Normethadone	The risk or severity of adverse effects can be increased when Diphenidol is combined with Normethadone.
Piritramide	The risk or severity of adverse effects can be increased when Diphenidol is combined with Piritramide.
Alphaprodine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Alphaprodine.
Nicomorphine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Nicomorphine.
Meptazinol	The risk or severity of adverse effects can be increased when Diphenidol is combined with Meptazinol.
Phenoperidine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Phenoperidine.
Phenazocine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Phenazocine.
Tilidine	The risk or severity of adverse effects can be increased when Diphenidol is combined with Tilidine.
Carfentanil, C-11	The risk or severity of adverse effects can be increased when Diphenidol is combined with Carfentanil, C-11.
Benzhydrocodone	The risk or severity of adverse effects can be increased when Diphenidol is combined with Benzhydrocodone.
Naloxegol	The risk or severity of adverse effects can be increased when Diphenidol is combined with Naloxegol.
Trospium	The risk or severity of adverse effects can be increased when Trospium is combined with Diphenidol.
Oxyphenonium	The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Diphenidol.
Benzatropine	The risk or severity of adverse effects can be increased when Benzatropine is combined with Diphenidol.
Disopyramide	The risk or severity of adverse effects can be increased when Disopyramide is combined with Diphenidol.
Metixene	The risk or severity of adverse effects can be increased when Metixene is combined with Diphenidol.
Terfenadine	The risk or severity of adverse effects can be increased when Terfenadine is combined with Diphenidol.
Buclizine	The risk or severity of adverse effects can be increased when Buclizine is combined with Diphenidol.
Trihexyphenidyl	The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Diphenidol.
Oxyphencyclimine	The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Diphenidol.
Procyclidine	The risk or severity of adverse effects can be increased when Procyclidine is combined with Diphenidol.
Hyoscyamine	The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Diphenidol.
Methscopolamine bromide	The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Diphenidol.
Darifenacin	The risk or severity of adverse effects can be increased when Darifenacin is combined with Diphenidol.
Tridihexethyl	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Diphenidol.
Anisotropine methylbromide	The risk or severity of adverse effects can be increased when Anisotropine methylbromide is combined with Diphenidol.
Atropine	The risk or severity of adverse effects can be increased when Atropine is combined with Diphenidol.
Nicardipine	The risk or severity of adverse effects can be increased when Nicardipine is combined with Diphenidol.
Mecamylamine	The risk or severity of adverse effects can be increased when Mecamylamine is combined with Diphenidol.
Pirenzepine	The risk or severity of adverse effects can be increased when Pirenzepine is combined with Diphenidol.
Homatropine methylbromide	The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Diphenidol.
Benzquinamide	The risk or severity of adverse effects can be increased when Benzquinamide is combined with Diphenidol.
Propantheline	The risk or severity of adverse effects can be increased when Propantheline is combined with Diphenidol.
Dicyclomine	The risk or severity of adverse effects can be increased when Dicyclomine is combined with Diphenidol.
Tropicamide	The risk or severity of adverse effects can be increased when Tropicamide is combined with Diphenidol.
Cocaine	The risk or severity of adverse effects can be increased when Cocaine is combined with Diphenidol.
Quinidine	The risk or severity of adverse effects can be increased when Quinidine is combined with Diphenidol.
Amantadine	The risk or severity of adverse effects can be increased when Amantadine is combined with Diphenidol.
Methantheline	The risk or severity of adverse effects can be increased when Methantheline is combined with Diphenidol.
Cycrimine	The risk or severity of adverse effects can be increased when Cycrimine is combined with Diphenidol.
Cyclopentolate	The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Diphenidol.
Tolterodine	The risk or severity of adverse effects can be increased when Tolterodine is combined with Diphenidol.
Oxybutynin	The risk or severity of adverse effects can be increased when Oxybutynin is combined with Diphenidol.
Pentolinium	The risk or severity of adverse effects can be increased when Pentolinium is combined with Diphenidol.

Target Protein

Muscarinic acetylcholine receptor M4 CHRM4

Muscarinic acetylcholine receptor M2 CHRM2

Muscarinic acetylcholine receptor M1 CHRM1

Muscarinic acetylcholine receptor M3 CHRM3

Referensi & Sumber

Synthesis reference: Miescher, K. and Marxer, A.; U.S. Patent 2,411,664; November 26, 1946; assigned to Ciba Pharmaceutical Products, Inc.

Link

Link

Contoh Produk & Brand

Produk: 1 • International brands: 3

Produk

Vontrol

Tablet • 25 mg/1 • Oral • US • Approved

International Brands

Satanolon — Tatsumi Kagaku
Verterge
Yesdol

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.

Peringatan Keamanan

Deskripsi

Struktur Molekul 2D

Deskripsi metode visualisasi

1. Pendahuluan & Konsep

2. Sumber Data (Validasi)

3. Algoritma Visualisasi

4. Legenda Visual